Correlations Among Subcutaneous Immunoglobulin Dosage, Immunoglobulin G Serum Pre-infusional Levels and Body Mass Index in Primary Antibody Deficiency Patients: A Pooled Analysis from the SHIFT/IBIS Studies.

Antonio Pecoraro Silvia Ricci Alessandra VultaggioGiorgio Maria BoggiaGiuseppe Spadaronull null

Published in: Clinical drug investigation (2020)

These findings support the concept that the cumulative monthly dose of SCIG and the dose of SCIG per kilogram of body weight affect IgG trough levels in PAD patients, irrespective of BMI.

Keyphrases

body mass index
end stage renal disease
ejection fraction
body weight
newly diagnosed
chronic kidney disease
prognostic factors
weight gain
replacement therapy